Castle Biosciences, Inc. (CSTL)
33.79
-0.71
(-2.06%)
USD |
NASDAQ |
Nov 13, 16:00
33.77
-0.02
(-0.06%)
After-Hours: 19:59
Castle Biosciences Enterprise Value : 798.68M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 798.68M |
| November 12, 2026 | 820.53M |
| November 11, 2026 | 804.83M |
| November 10, 2026 | 818.06M |
| November 09, 2026 | 816.83M |
| November 06, 2026 | 759.60M |
| November 05, 2026 | 811.29M |
| November 04, 2026 | 858.99M |
| November 03, 2026 | 840.22M |
| November 02, 2026 | 834.07M |
| October 30, 2026 | 902.38M |
| October 29, 2026 | 943.92M |
| October 28, 2026 | 887.61M |
| October 27, 2026 | 820.83M |
| October 26, 2026 | 783.60M |
| October 23, 2026 | 776.83M |
| October 22, 2026 | 780.22M |
| October 21, 2026 | 816.53M |
| October 20, 2026 | 778.98M |
| October 19, 2026 | 748.67M |
| October 16, 2026 | 742.37M |
| October 15, 2026 | 798.99M |
| October 14, 2026 | 777.75M |
| October 13, 2026 | 770.68M |
| October 12, 2026 | 766.98M |
| Date | Value |
|---|---|
| October 09, 2026 | 818.06M |
| October 08, 2026 | 796.22M |
| October 07, 2026 | 774.37M |
| October 06, 2026 | 785.45M |
| October 05, 2026 | 886.68M |
| October 02, 2026 | 853.14M |
| October 01, 2026 | 843.76M |
| September 30, 2026 | 852.22M |
| September 29, 2026 | 833.98M |
| September 28, 2026 | 866.02M |
| September 25, 2026 | 862.35M |
| September 24, 2026 | 843.44M |
| September 23, 2026 | 833.98M |
| September 22, 2026 | 833.07M |
| September 21, 2026 | 837.34M |
| September 18, 2026 | 848.02M |
| September 17, 2026 | 891.95M |
| September 16, 2026 | 852.29M |
| September 15, 2026 | 852.90M |
| September 14, 2026 | 790.05M |
| September 11, 2026 | 756.18M |
| September 10, 2026 | 755.88M |
| September 09, 2026 | 755.57M |
| September 08, 2026 | 769.30M |
| September 04, 2026 | 773.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| RadNet, Inc. | 7.758B |
| Lumexa Imaging Holdings, Inc. | 2.310B |
| Quest Diagnostics, Inc. | 34.44B |
| Labcorp Holdings, Inc. | 36.61B |
| OPKO Health, Inc. | 1.321B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.10M |
| Revenue (Quarterly) | 102.89M |
| Total Expenses (Quarterly) | 106.99M |
| EPS Diluted (Quarterly) | -0.1338 |
| Gross Profit Margin (Quarterly) | 74.00% |
| Profit Margin (Quarterly) | -3.98% |
| Earnings Yield | -2.27% |
| Normalized Earnings Yield | -1.970 |